A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors

Title
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors
Authors
Keywords
TRC102, Base excision repair, Methoxyamine, Pemetrexed, First-in-human, Phase 1
Journal
INVESTIGATIONAL NEW DRUGS
Volume 31, Issue 3, Pages 714-723
Publisher
Springer Nature
Online
2012-09-30
DOI
10.1007/s10637-012-9876-9

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search